戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ay play a role in neoangiogenesis (postnatal vasculogenesis).
2 rting their role in directional induction of vasculogenesis.
3 cule 1 (PECAM), and aquaporin 1, a marker of vasculogenesis.
4 ate PDGF-BB as a primary effector of MM cell vasculogenesis.
5 es, thereby increasing both angiogenesis and vasculogenesis.
6  to study VEGFR-1 activation in pathological vasculogenesis.
7 GF-1R(+) hCSCs improved cardiomyogenesis and vasculogenesis.
8 and pathologic processes involving postnatal vasculogenesis.
9 ucial downstream pathway leading to aberrant vasculogenesis.
10  in vitro before implantation also inhibited vasculogenesis.
11 s, which themselves form by the mechanism of vasculogenesis.
12 vel therapeutic target for the inhibition of vasculogenesis.
13 poiesis, but not primitive erythropoiesis or vasculogenesis.
14 xial vessels during angioblast migration and vasculogenesis.
15 ateral plate mesoderm by Hh signaling during vasculogenesis.
16 tional blood vessels during angiogenesis and vasculogenesis.
17 "angioblast" progenitors in a process called vasculogenesis.
18  play a critical role in postnatal and tumor vasculogenesis.
19  effects contributed to cardiomyogenesis and vasculogenesis.
20 e developmental regulation of hemostasis and vasculogenesis.
21 lls (ECs) and smooth muscle cells (SMCs) and vasculogenesis.
22 urvival signaling via the promotion of tumor vasculogenesis.
23 ascularization, and in vivo studies of human vasculogenesis.
24 nsights into the role of NRP-1 in a model of vasculogenesis.
25 ys that may mediate glycocalyx regulation of vasculogenesis.
26 t affect MM cell migration, organization, or vasculogenesis.
27 rowth factor (VEGF), which in turn regulates vasculogenesis.
28 d3(-/-) mice, a model of bone marrow-derived vasculogenesis.
29  confirmed a deficit in bone marrow-mediated vasculogenesis.
30 ord blood-derived EPCs in a model of in vivo vasculogenesis.
31 transplantation experiments to examine human vasculogenesis.
32  to demonstrate a crucial role for Zimp10 in vasculogenesis.
33 othelial cells and is critical for embryonic vasculogenesis.
34  10, although there were no overt effects on vasculogenesis.
35 ovascularization, a process termed postnatal vasculogenesis.
36 d in neural crest cell (NCC) development and vasculogenesis.
37 epresents a critical force that drives adult vasculogenesis.
38 , expression in nonvasculogenic cells caused vasculogenesis.
39 ed that tumor cell-secreted factors regulate vasculogenesis.
40 lial lineages, rescues hematopoiesis but not vasculogenesis.
41 f circulating stem cells is a key feature of vasculogenesis.
42 the setting of compromised host angiogenesis/vasculogenesis.
43 r normalize vasculature rather than initiate vasculogenesis.
44 cardially derived and essential for coronary vasculogenesis.
45 ration, extracellular matrix remodeling, and vasculogenesis.
46 the growth of blood vessels during postnatal vasculogenesis.
47 early embryonic development including normal vasculogenesis.
48 n revealed a requirement for YAP in yolk sac vasculogenesis.
49 present study evaluates the role of KCNH2 in vasculogenesis.
50 l endothelial cell behavior during embryonic vasculogenesis.
51 ions results in defects in cardiogenesis and vasculogenesis.
52 t E11.5-12.5 days with associated defects in vasculogenesis.
53 auses embryonic lethality at E15.5 with poor vasculogenesis.
54 processes: angiogenesis, arteriogenesis, and vasculogenesis.
55 angioblastomas are a result of tumor-derived vasculogenesis.
56 onstrated downregulation of genes related to vasculogenesis.
57 ed by NO deficiency may trigger MSC-mediated vasculogenesis.
58 , TGF-beta1-associated fibrosis and impaired vasculogenesis.
59 g both fetoplacental vascular resistance and vasculogenesis.
60 novo from the mesoderm in a process known as vasculogenesis.
61 ory role of S-nitrosylation signaling in MSC vasculogenesis.
62 he coronary vasculature during early cardiac vasculogenesis.
63 actors (HIFs) and the patterning of coronary vasculogenesis.
64  CD31, indicating potential roles of MLL1 in vasculogenesis.
65 lar development which include: (1) defective vasculogenesis, (2) hypoplasia of the right ventricle, (
66 mportant function in tissue regeneration and vasculogenesis after injury.
67 tion; and vasoformative responses, including vasculogenesis, alternative angiogenic pathways, and vas
68 functions for plexinD1 in post-natal retinal vasculogenesis and adult angiogenesis through the use of
69                                 Importantly, vasculogenesis and angioblast differentiation steps were
70 ing embryogenesis, flk1 is required for both vasculogenesis and angiogenesis and abnormally elevated
71 Cdc42 in ECs caused embryonic lethality with vasculogenesis and angiogenesis defects.
72 thelial growth factor (VEGF) is required for vasculogenesis and angiogenesis during embryonic and ear
73 )-2C is thought to play an important role in vasculogenesis and angiogenesis during vascular developm
74       The requirement for Notch signaling in vasculogenesis and angiogenesis is well documented.
75 sue of the JCI, Kioi et al. demonstrate that vasculogenesis and angiogenesis potentially play distinc
76 perinatal vascular development revealed that vasculogenesis and angiogenesis proceed normally in thes
77 ntegrins in their endothelial cells, initial vasculogenesis and angiogenesis proceed normally, at lea
78 lex and requires a number of steps including vasculogenesis and angiogenesis that are followed by dif
79 dothelial lineage and neovascular processes (vasculogenesis and angiogenesis) we evaluated endothelia
80 ic mouse has been an excellent tool to study vasculogenesis and angiogenesis, a lymphatic-specific fl
81 re required in endothelial cells for initial vasculogenesis and angiogenesis, although they are requi
82  vasculature forms via the dual processes of vasculogenesis and angiogenesis, and is regulated at mul
83 and AcSDKP as potent stimulators of coronary vasculogenesis and angiogenesis, and reveals Tbeta4-indu
84  is thought to originate by a combination of vasculogenesis and angiogenesis, but how these processes
85 rowth factor (VEGF)-A has essential roles in vasculogenesis and angiogenesis, but the downstream step
86                                       During vasculogenesis and angiogenesis, endothelial cell respon
87 ell specification and differentiation during vasculogenesis and angiogenesis.
88  been shown to be important during embryonic vasculogenesis and angiogenesis.
89 gulates EC proliferation and adhesion during vasculogenesis and angiogenesis.
90 y may be attributable to defects in yolk sac vasculogenesis and angiogenesis.
91 ive hematopoiesis and the inhibition of both vasculogenesis and angiogenesis.
92 wth factor-A (VEGF-A) signaling directs both vasculogenesis and angiogenesis.
93 ve model for the study of human disorders of vasculogenesis and angiogenesis.
94 odulate phosphotyrosine signaling to promote vasculogenesis and angiogenesis.
95 lective behavior of endothelial cells during vasculogenesis and angiogenesis.
96                                   Attenuated vasculogenesis and cardiogenesis during recovery were ev
97 ants revealed important functions of PTIP in vasculogenesis and chorioplacental development that appe
98 al lineage leading to both HSC emergence and vasculogenesis and determine that a single miRNA, miR-14
99 tivation of Tbeta4 is essential for yolk sac vasculogenesis and embryonic survival, and administratio
100  known as a cytokine essential for embryonic vasculogenesis and for the angiogenesis associated with
101  of VEGF signaling in the earliest events in vasculogenesis and found that it exerts critical effects
102 iRNA in a human embryonic stem cell model of vasculogenesis and found that miR-132 was highly express
103 cating a highly conserved role in vertebrate vasculogenesis and haematopoiesis.
104                           PURPOSE OF REVIEW: Vasculogenesis and hematopoiesis are essential for devel
105 actor Etsrp/Etv2/ER71 has been implicated in vasculogenesis and hematopoiesis in multiple vertebrates
106  cofactors will lead to greater insight into vasculogenesis and hematopoiesis, and may help to identi
107 y reported Etv2 as an essential regulator of vasculogenesis and hematopoiesis.
108 been identified as an essential regulator of vasculogenesis and hematopoiesis.
109 at moderate doses, ethanol directly promotes vasculogenesis and improves microvascular function, resu
110 tment and endothelial cell activation during vasculogenesis and ischemia-mediated arteriogenesis coul
111  Our results suggest a role for adenosine in vasculogenesis and its potential use to stimulate engraf
112 trophils recently identified as mediators of vasculogenesis and metastasis, were recruited to the tum
113  Ly6G antibodies prevented ELF5 from driving vasculogenesis and metastasis.
114 es have implicated hypoxia in the control of vasculogenesis and permeability, the basis for which is
115 le roles for MT1-MMP or MT2-MMP in placental vasculogenesis and provide the first example of selectiv
116 imulations quantitatively reproduce in vitro vasculogenesis and subsequent in vitro remodeling.
117 storing the radiation-damaged vasculature by vasculogenesis and thereby allowing the growth of surviv
118 nstrates that Sag is essential for embryonic vasculogenesis and tumor angiogenesis, and provides the
119 t MLL1 is a key factor in hypoxia signaling, vasculogenesis and tumor growth, and its depletion suppr
120 pulation that appears to participate in both vasculogenesis and vascular homeostasis.
121 in essential processes such as angiogenesis, vasculogenesis and vascular permeability.
122 ole for Cx43alpha1 gap junctions in coronary vasculogenesis and vascular remodeling.
123 ial progenitor cells (EPCs) are essential in vasculogenesis and wound healing, but their circulating
124 or the differentiation of endothelial cells (vasculogenesis) and for the sprouting of new capillaries
125 s regulating de novo blood vessel formation (vasculogenesis) and remodeling (angiogenesis) come from
126 ion of vessels from endothelial progenitors (vasculogenesis) and sprouting of vessels from pre-existi
127 rnal spiral arterioles, dysregulated villous vasculogenesis, and abundant fibrin deposition are chara
128 ll junctions regulate vascular permeability, vasculogenesis, and angiogenesis.
129 lopmental processes including hematopoiesis, vasculogenesis, and cardiogenesis.
130 mental processes such as boundary formation, vasculogenesis, and cell migration.
131             Fluid flow is also important for vasculogenesis, and evidence suggests that fluid shear s
132  tumor metrics are quantified (e.g., growth, vasculogenesis, and metastasis).
133 low in the main trunk vessels, which form by vasculogenesis, and the intersomitic vessels, which form
134 leading to major insights into angiogenesis, vasculogenesis, and tumor biology.
135  genes involved in embryonic development and vasculogenesis, and up-regulation of genes involved in h
136 nteraction between SEMA3A and VEGF164 during vasculogenesis, angiogenesis or limb axon patterning, su
137                                              Vasculogenesis, angiogenesis, and maturation are three m
138 acellular matrix, are critical regulators of vasculogenesis, angiogenesis, endothelial repair, and sh
139 ctors with roles in development that include vasculogenesis, angiogenesis, haematopoiesis and bone de
140 ized by high expression of genes involved in vasculogenesis, angiogenesis, tumorigenesis and associat
141 ph cell-signaling pathways known to regulate vasculogenesis/angiogenesis.
142 d determining the effects of the knockout on vasculogenesis, angiogenic remodeling, and the regulatio
143                        Both angiogenesis and vasculogenesis are disrupted in the hyperoxia-induced va
144 target of Hand1 and reveal impaired yolk sac vasculogenesis as a primary cause of early embryonic let
145  Formation of embryonic vasculature involves vasculogenesis as endothelial cells differentiate and ag
146                                  The role of vasculogenesis as opposed to angiogenesis in tumor forma
147 ed by fibrobalst growth factor receptor 1 in vasculogenesis as vascular endothelial growth factor sup
148                Recent evidence suggests that vasculogenesis as well as angiogenesis occurs throughout
149 ctors, and, in part, directly contributed to vasculogenesis, as demonstrated by both 3D confocal micr
150 of the identified proteins was assessed in a vasculogenesis assay in vivo by using a morpholino strat
151 an umbilical vein endothelial cells and in a vasculogenesis assay in which differentiated embryonic s
152               This caused defective coronary vasculogenesis associated with impaired vascular smooth
153 work formation is enriched for migration and vasculogenesis-associated genes that predict survival in
154  Taken together, CUL2 is required for normal vasculogenesis, at least in part mediated by its regulat
155 growth factor (VEGF) plays a crucial role in vasculogenesis (blood vessel formation) and angiogenesis
156  (RTK) signaling and play important roles in vasculogenesis, bone morphogenesis, and renal uteric bra
157  cardiac looping and have defective yolk sac vasculogenesis, both cardiac and yolk sac morphology of
158  in common for developmental cell migration, vasculogenesis, branching morphogenesis, as well as neur
159 primary vascular plexus indicative of intact vasculogenesis but failed to induce the secondary vascul
160  UBR4-deficient YS normally advances through vasculogenesis but is arrested during angiogenic remodel
161 spo1 receptor kremen form primary vessels by vasculogenesis, but are defective in subsequent angiogen
162 y participate in the modulation of postnatal vasculogenesis by inhibiting EPC differentiation.
163  neovascular microenvironment may facilitate vasculogenesis by promoting endothelial differentiation
164 udy elucidates the potential coregulation of vasculogenesis by the heparan sulfate glycosaminoglycan-
165 hese studies indicate that tubulogenesis and vasculogenesis can be partially recapitulated by recombi
166                             During embryonic vasculogenesis, CD24 expression is down-regulated in hum
167 P in the developmental processes of yolk sac vasculogenesis, chorioallantoic attachment, and embryoni
168 electively targeted endothelium generated by vasculogenesis, completely inhibiting vessel formation m
169 as emerged as an advantageous model to study vasculogenesis, cranial vasculature is thought to origin
170 k-in of the TGF-beta3 ligand can prevent the vasculogenesis defects and autoimmunity associated with
171 splay the major features of Tgfb1(-/-) mice (vasculogenesis defects, multiorgan inflammation, and lac
172 nto the germ line of mice (ILK-VT/GG) caused vasculogenesis defects, resulting in a general developme
173                                 We show that vasculogenesis-driven and angiogenesis-driven tumors gro
174 ator of endothelial cell differentiation and vasculogenesis during both development and tumor vascula
175 ransforming growth factor beta activation in vasculogenesis during development, immune regulation, an
176 protein required for proper angiogenesis and vasculogenesis during development.
177 nown for its involvement in angiogenesis and vasculogenesis during ontogeny.
178         Differing from both angiogenesis and vasculogenesis, during canalogenesis SECs express Prox1,
179 Unlike angiogenesis and similar to stages of vasculogenesis, during canalogenesis tip cells divide an
180                       In the first stages of vasculogenesis, endothelial cells elongate and form a ne
181 n solid tumors, hypoxia triggers an aberrant vasculogenesis, enhances malignant character, and elevat
182 by hemo-vasculogenesis, the process by which vasculogenesis, erythropoiesis, and hematopoiesis occur
183 otein (BMP) antagonist capable of inhibiting vasculogenesis even in the presence of provasculogenic V
184 igration, controlled cellular proliferation, vasculogenesis, extracellular matrix and hormone secreti
185 ve extraembryonic mesoderm morphogenesis and vasculogenesis, failure to close the ectoplacental cavit
186  and pathophysiological processes, including vasculogenesis, fibrosis, cholestatic pruritus and tumou
187  erythroid cells, and an absence of yolk sac vasculogenesis, followed by embryonic lethality at embry
188 , vascular progenitor cell-driven 'postnatal vasculogenesis' has been suggested as an important mecha
189  target), zCul2 morpholino blocked embryonic vasculogenesis in a manner similar to that caused by inh
190 , a VEGFR1-specific agonist, increased tumor vasculogenesis in a murine BMT model.
191 s exhibited markedly diminished capacity for vasculogenesis in an in vitro Matrigel tube-forming assa
192 ould replace the ability of serum to promote vasculogenesis in cultured allantois explants.
193          Whether Sag is required for de novo vasculogenesis in embryos and angiogenesis in tumors is
194 nesis and cardiac development, have aberrant vasculogenesis in embryos, yolk sacs and placentas, and
195                 These findings indicate that vasculogenesis in endometriotic lesions is dependent on
196 rate that the inhibition of COX-2 suppresses vasculogenesis in endometriotic lesions, which may contr
197 lture model would most closely correspond to vasculogenesis in flat areas of the embryo like the yolk
198 ses of vascular co-option, angiogenesis, and vasculogenesis in gliomas have been extensively describe
199                     Our results suggest that vasculogenesis in human MM may develop from tumoral prod
200 at mutant ZNF408 results in abnormal retinal vasculogenesis in humans and is associated with FEVR.
201  differentiation that underpins pathological vasculogenesis in IH.
202 nd thereby promote cellular interactions and vasculogenesis in IH.
203 ulated MM cell proliferation, migration, and vasculogenesis in monolayer and organization of the cell
204 utics to normalize impaired ischemia-induced vasculogenesis in patients with diabetes.
205  for this compound in ECs) strongly disrupts vasculogenesis in pluripotent embryonic stem cell cultur
206               We found that VJ115 suppressed vasculogenesis in Tg(fli1-eGFP) embryos and impaired cir
207                        A role for PDGF-BB in vasculogenesis in the 3D MM/UB co-culture system was val
208      Surprisingly, c-myc is not required for vasculogenesis in the embryo.
209 XBP1 (XBP1ecko) in mice retarded the retinal vasculogenesis in the first 2 postnatal weeks and impair
210 the Mekk3 gene to evaluate the importance of vasculogenesis in the formation of Ewing's sarcoma tumor
211 ne led to dose-dependent inhibition of tumor vasculogenesis in the murine model.
212                     These included defective vasculogenesis in the placental labyrinth, a collapsed e
213 asculature are distinct from those governing vasculogenesis in the rest of the embryo.
214 as both necessary and sufficient to initiate vasculogenesis in the zebrafish embryos.
215 ed experiments to identify the exact role of vasculogenesis in tumor progression.
216               There was a marked increase in vasculogenesis in vitro as measured by angiogenesis assa
217 deal platform for the investigation of renal vasculogenesis in vitro.
218 n of endothelial progenitor cells capable of vasculogenesis in vivo and may provide endogenous cues t
219  pericyte/vSMC formation in vitro and during vasculogenesis in vivo using 2 Ewing sarcoma mouse model
220 F-A in hemangioma-derived stem cells reduced vasculogenesis in vivo.
221 f VEGF-A expression in these cells inhibited vasculogenesis in vivo.
222  levels at the site of tumor growth promoted vasculogenesis in vivo.
223 for the investigation of mutations affecting vasculogenesis in zebrafish.
224   These findings support animal studies that vasculogenesis, in addition to angiogenesis, may contrib
225 v2 activates expression of genes involved in vasculogenesis, including Fli1.
226 disrupt specific stages of hematopoiesis and vasculogenesis, including the cloche, spadetail (tbx16),
227 ng surfactant lipid and protein homeostasis, vasculogenesis, including Vegfa, and smooth muscle cell
228 nce of endothelial progenitor cells in adult vasculogenesis increased further, the role of these como
229 many of the defects responsible for impaired vasculogenesis involve HIF1-regulated genes, we hypothes
230 ericyte recruitment to EC-lined tubes during vasculogenesis is a stimulatory event controlling vascul
231                                  Therapeutic vasculogenesis is an emerging concept that can potential
232                   Our findings indicate that vasculogenesis is critical in the expansion of the tumor
233                    An unresolved question in vasculogenesis is how mammalian endothelial cells make l
234  angiogenesis is normal in the model whereas vasculogenesis is impaired.
235 helial cells initiate lumen formation during vasculogenesis is not known.
236 ted to mammals a normal component of primary vasculogenesis is production of endothelial cells that e
237                   Furthermore, we found that vasculogenesis is significant for tumors because it gene
238                                     Coronary vasculogenesis is significantly impaired in null mice, w
239 ole of bone morphogenetic proteins (BMPs) in vasculogenesis is still not well understood, despite man
240                                      (ii) If vasculogenesis is the dominant process, then the tumor m
241  new blood vessels from preexisting vessels; vasculogenesis is the formation of new vessels by recrui
242 y genes associated with learning and memory, vasculogenesis, neurogenesis, cell survival pathways, Ab
243 atopoiesis (no effect on gata1 or h-bae1) or vasculogenesis (no effect on kdrl, ephb2a, notch3, dab2,
244                     In Hand1-null yolk sacs, vasculogenesis occurs but vascular refinement was arrest
245                                              Vasculogenesis occurs normally in mice lacking VE-PTP; h
246 erentiation of mesenchymal cells and reduced vasculogenesis of the splenic primordium.
247                                       Severe vasculogenesis or angiogenesis defects in embryos are in
248  genes and involvement of pathways common to vasculogenesis or angiogenesis in other parts of the emb
249 on pathways that are known to be involved in vasculogenesis or angiogenesis, were found to have expre
250 e formation using in vitro assays that mimic vasculogenesis or angiogenic sprouting in 3D collagen ma
251 f existing NV, without appreciably affecting vasculogenesis or retinal revascularization.
252                  Blood vessels form de novo (vasculogenesis) or upon sprouting of capillaries from pr
253 d cells affect cardiac development, yolk sac vasculogenesis, or viability in the mouse.
254 Combined SDF-1 and VEGF expression augmented vasculogenesis over SDF-1 expression alone.
255 ent of GBM: in addition to radiotherapy, the vasculogenesis pathway needs to be blocked, and this can
256 rvations indicate that dysregulated coronary vasculogenesis plays a pivotal role in formation of the
257  activated in endothelial progenitors during vasculogenesis prior to blood vessel morphogenesis and i
258                        In striking contrast, vasculogenesis proceeded in both the allantois and the e
259   In Etsrp knockdown embryos initial cranial vasculogenesis proceeds normally but endothelial and mye
260 airs surrogate markers of tumor angiogenesis/vasculogenesis, providing support for the concept that E
261                             However, de novo vasculogenesis remained intact, consistent with the diff
262 s been well characterized, its role in adult vasculogenesis remains poorly understood.
263 , and the role of Tbx5 in mammalian coronary vasculogenesis, remains largely unknown.
264 lysis at 3 developmental stages critical for vasculogenesis revealed a cascade of pathways that may m
265 een the glycome and the transcriptome during vasculogenesis, revealing the possibility of harnessing
266 interrogation reveals an atypical VEGF-based vasculogenesis signalling that facilitates recruitment o
267  (VCAM-1) were performed in murine models of vasculogenesis (subcutaneous matrigel) or hind-limb isch
268 nuum mathematical models to explore in vitro vasculogenesis: such models describe cell ensembles but
269 he yolk sac and dorsal aorta, that undergoes vasculogenesis, the de novo formation of blood vessels.
270                                              Vasculogenesis, the de novo growth of the primary vascul
271                  Mechanisms underlying tumor vasculogenesis, the homing and engraftment of bone marro
272  like the choriocapillaris, develops by hemo-vasculogenesis, the process by which vasculogenesis, ery
273 and heterotypic signals that enhance TAM and vasculogenesis, these processes may contribute to NF-kap
274                     Tissue ischemia promotes vasculogenesis through chemokine-induced recruitment of
275                              CLIC4 regulates vasculogenesis through endothelial tube formation.
276 e a novel multicellular agent-based model of vasculogenesis using the CompuCell3D modeling environmen
277  the potential of two principal effectors of vasculogenesis, vascular endothelial growth factor A (VE
278 described: vascular co-option, angiogenesis, vasculogenesis, vascular mimicry, and (the most recently
279 Nonetheless, recent studies demonstrate that vasculogenesis, vascular remodeling, and angiogenesis ar
280 hus conclude that in addition to endothelial vasculogenesis, VEGF can induce renal epithelial cell mo
281 st local VEGF and/or PlGF expression promote vasculogenesis; VEGF plays a role in EPC recruitment and
282 ting that GATA transcription factors promote vasculogenesis via activation of downstream targets, whi
283                     Histological analysis of vasculogenesis was performed with platelet endothelial c
284 nduced arteriogenesis, whereas developmental vasculogenesis was unaffected.
285  whether Myc indeed contributes to embryonic vasculogenesis we evaluated Myc function in Xenopus laev
286 fragility and subsequent defects in yolk sac vasculogenesis, we expressed Tmod1 specifically in the m
287 een the glycome and the transcriptome during vasculogenesis, we identified by microarray and then val
288  To explore a potential role of Flk-1 in the vasculogenesis, we investigated two glioblastoma cell li
289          Using a 3D in vitro tissue model of vasculogenesis, we observed increased vascularization in
290  placental labyrinth, basement membranes and vasculogenesis were normal in embryo and yolk sac.
291 erentiation of endothelial cells is known as vasculogenesis, whereas the growth of new blood vessels
292  exhibit severe defects in hematopoiesis and vasculogenesis, whereas the single knockouts do not.
293 l with the capacity for cardiomyogenesis and vasculogenesis which contribute, at least in part, to th
294 on depends on not only angiogenesis but also vasculogenesis, which is mediated through mobilization o
295 reduction in proliferation and impairment of vasculogenesis, which were associated with induction of
296 als that NHFs enhance blastema formation and vasculogenesis, while MWFs inhibit fibrogenesis and indu
297 suggested that these blood vessels formed by vasculogenesis, while the current concept seems to favor
298 lular proliferation in the midface, aberrant vasculogenesis with decreased productive vessel branchin
299 eby provide a novel mechanism for regulating vasculogenesis, with direct relevance to physiological a
300 tinct cytokine binding domains, has roles in vasculogenesis, wound healing responses, and fibrogenesi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top